Finch Therapeutics enters contingent lease termination agreement for Somerville facility

Finch Therapeutics Group, Inc.

Lease termination contingent on landlord signing new tenant lease for 36,285 sq ft at 200 Inner Belt Road, Somerville.
Termination date would be later of May 31, 2023 or three days after new lease execution.
If no new lease by June 30, 2023, agreement void and lease continues through September 2026.
Security deposit of $199,467 to be returned to Finch upon termination and surrender of premises.
Company represents no active subleases; prior sublease to Microbiome Health Research Institute has expired.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Finch Therapeutics Group, Inc. terminated Lease Termination Agreement with NRL WCS 200 Inner Belt Prop, LLC (effective 2023-05-12).

Action: termination
Agreement: lease
Counterparty: NRL WCS 200 Inner Belt Prop, LLC
Effective: 2023-05-12

Exact text from the filing

On May 12, 2023, Finch Therapeutics Group, Inc. (the “Company”) entered into a Lease Termination Agreement (the “Agreement”) with NRL WCS 200 Inner Belt Prop, LLC, a Delaware limited liability company (the “Landlord”), related to the office lease agreement

View on SEC.gov

Browse all material agreements →

Finch Therapeutics Group, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-148134

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.